You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Israel

Jul 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Israel with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Israel, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Israel for free:

The Consumer Health in Israel market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Israel?
  • What are the major brands in Israel?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Vitamins and dietary supplements drive consumer health sales in 2010

During 2010, the consumer health market as a whole witnessed healthy growth, although slightly slower than that seen over the review period as a whole. The main growth engine in consumer health was the growing popularity of vitamins and dietary supplements. OTC products also saw positive growth during 2010, but at a decreasing rate as new alternatives began to gain popularity.

Consumer health professionals become opinion leaders within vitamins and dietary supplements

The growing popularity of unconventional medicine and treatments, and their becoming more mainstream amongst Israeli consumers to treat medical problems, has contributed to the success of vitamins and dietary supplements. In 2010, there was stronger growth in vitamins and dietary supplements than in over-the-counter products, as consumers were keener on preventative medicine and were seeking more natural alternatives within certain categories.

A new emergency contraception brand enters the market

In December 2010, a new brand entered emergency contraception. Previously, Trima held a monopoly within emergency contraception, through its brand Prostinor. The new brand, Norlevo, was launched by CTS Ltd and is expected to change the competitive environment significantly in 2011.

Health food shop retailers gain distribution share

Thanks to the strong growth of vitamins and dietary supplements over the recent years and the stronger trade-off between vitamins and dietary supplements products and OTC health food shops managed to gain stronger distribution share in 2010. Health food shops are a main channel through which vitamins and dietary supplements products are sold in Israel as they tend to hold wider varieties, offer better discounts, hold private label brands and have professional staff within outlets.

Consumer health is expected to witness a slowdown over the forecast period

Consumer health sales will continue to go up over the forecast period as consumers increasingly resort of over the counter remedies such as analgesics or cough, cold and allergy remedies for common ailments such as a colds, headaches or flu before taking time to make an appointment and visit a doctor. Moreover, some consumers will increasingly choose to prevent disease rather than cure it, thus vitamins and dietary supplements and other products such as smoking cessation remedies will continue to post strong growth rates over the forecast period.

Table of Contents

Table of Contents

Consumer Health in Israel - Industry Overview

EXECUTIVE SUMMARY

Vitamins and dietary supplements drive consumer health sales in 2010

Consumer health professionals become opinion leaders within vitamins and dietary supplements

A new emergency contraception brand enters the market

Consumer health is expected to witness a slowdown over the forecast period

KEY TRENDS AND DEVELOPMENTS

Vitamin and dietary supplement players target professionals as opinion leaders

More specific products a key trend in vitamins and dietary supplements

Changing consumer behaviour seen within consumer health during 2010

Consumer health players seek opportunities outside OTC products

Late winter has a negative impact on consumer health sales in 2010

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010

MARKET DATA

  • Table 2 Sales of Consumer Health by Category: Value 2005-2010
  • Table 3 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 4 Consumer Health Company Shares by Value 2006-2010
  • Table 5 Consumer Health Brand Shares by Value 2007-2010
  • Table 6 Penetration of Private Label by Category 2005-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Israel - Company Profiles

Dexxon Ltd in Consumer Health (Israel)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 4 Dexxon Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 5 Dexxon Ltd: Competitive Position 2010

Rekah Pharmaceutical Products Ltd in Consumer Health (Israel)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 8 Rekah Pharmaceutical Products Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 9 Rekah Pharmaceutical Products Ltd: Competitive Position 2010
  • Summary 10 Vitamed Pharmaceutical Industries Ltd: Competitive Position 2010

Ta'am Teva-Altman General Partnership in Consumer Health (Israel)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Ta’am Teva-Altman General Partnership: Competitive Position 2010

Teva Pharmaceutical Industries Ltd in Consumer Health (Israel)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 16 Teva Pharmaceutical Industries Ltd: Competitive Position 2010

Adult Mouth Care in Israel - Category Analysis

HEADLINES

TRENDS

  • Within adult mouth care, the over-the-counter drugs market does not provide a wide and sufficient range of products for the end user. In cases like this, companies within the general consumer health market seek more profitable ways to raise their sales by launching alternatives such as medical devices, cosmetic products and dietary supplements that treat the problem but are not regulated by the Ministry of Health in terms of pricing and other regulations. In addition, the growing demand for more natural and homoeopathic products has pushed consumers towards new alternatives. Within adult mouth care, alternative products have slowly begun to impact negatively demand for OTC products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Taro Pharmaceutical Industries Ltd continued to lead sales in 2010, with a value share of 25%. The company’s leading brand is Tarodent, with 21% of sales, supported by Anadent, with 4%. Taro managed to improve its competitive position in 2010, with an increase in share of almost one percentage point. Brand loyalty is not very high within the adult mouth care; however, consumers generally stick to well-known brands.

PROSPECTS

  • Israelis are expected to continue to seek more innovative products within adult mouth care that are easier for both external and internal use, and reduce the amount of contact between the end user and the actual product. For example, in 2010, there was growing demand for products that come with special sticks for application, as well as patches that dissolve to release the active ingredient.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 14 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Israel - Category Analysis

HEADLINES

TRENDS

  • Analgesics witnessed 5% current value terms growth in 2010, which was down slightly from the 7% review period CAGR. This slower growth was partially due to the late winter in Israel in 2010, causing consumers to stock up less on OTC products before the winter months. In addition, due to increasing desire for more natural-based products, more consumers prefer to consume vitamins and dietary supplements as a means of sickness prevention.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Pharmaceutical Industries Ltd continued to lead analgesics sales in Israel in 2010, with a 40% value share. This was mainly thanks to the continuing strong performance of its Acamol and Optalgin brands. Between 2008 and 2010, Teva witnessed a slight decrease in its share, due mainly to stronger demand for NSAIDS, such as ibuprofen, which is led by Reckitt Benckiser Israel Ltd.

PROSPECTS

  • The analgesics category is expected to grow at a CAGR of 2% in constant value terms over the forecast period. This is slower than the review period constant value CAGR of 4%. There is expected to be stronger demand for stronger products, such as ibuprofen and naproxen, while the largest category, acetaminophen, is seeing growth slow. The desire for more effective analgesics will encourage some consumers to consult a doctor, leading many to purchase prescription products. Growth will also continue to be hampered by the fact that pricing regulations limit players ability to raise their unit prices.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 20 Analgesics Company Shares by Value 2006-2010
  • Table 21 Analgesics Brand Shares by Value 2007-2010
  • Table 22 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Israel - Category Analysis

HEADLINES

TRENDS

  • A degree of polarisation was evident within the wider calming and sleeping products market in 2010, with many Israeli consumers consuming either strong Rx products on the one hand, or all-natural supplements on the other, while over-the-counter drug sales suffered. The high levels of stress and anxiety in Israel have caused Israeli consumers to self-medicate to treat sleeping problems. Family doctors are increasingly willing to prescribe strong prescription drugs in such circumstances.

SWITCHES

COMPETITIVE LANDSCAPE

  • Floris Ltd led sales of calming and sleeping products in 2010, with a 19% value share, thanks to its leading brand, Region Day. The continuous high stress level in Israel due to the unstable environment has driven demand for the brand.

PROSPECTS

  • The polarisation in sales between RX drugs and more “natural” products is expected to continue to have a negative impact on sales of OTC calming and sleeping products during the forecast period, as more and more Israelis will continue to seek either prescription drugs, on the one hand, or all natural supplements, on the other. High levels of stress will continue to characterise the Israeli environment, making such products more and more popular.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2005-2010
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 26 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 27 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Israel - Category Analysis

HEADLINES

TRENDS

  • As of 1 February 2010, the Israeli Ministry of Health approved new marketing regulations regarding oral cough, cold and allergy medicines in Israel. Based on findings by the US FDA and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the following new regulations were approved: sales of child-specific oral cough and cold remedies for children under the age of one year will be forbidden; in addition, child-specific products for children under the age of six will only be sold with a prescription. Children aged six and above can only use such products when purchased over the counter from a pharmacist. No GSL sales will be available. This change was made to regulate self-medication using such products, as such products can be extremely harmful to young children if not taken correctly.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cough, cold and allergy (hay fever) remedies continued to be led by Teva Pharmaceutical Industries Ltd in 2010, with a 26% value share. The company owns a wide range of brands, including Acamol, Coldex, Loratadine and Alrin. Teva has a strong reputation within Israel, with this factor being one of the main drivers of brand choice in the Israeli consumer health market. Teva tends to put a strong emphasis on marketing, and in 2010 it launched a new campaign for its new combination product: Acamol Cold & Flu.

PROSPECTS

  • 2011 is expected to witness stronger sales of cough and cold remedies, as the peak winter season in 2010/11, which would typically have started in November, did not occur, with temperatures still above 20ºC as of late December 2010.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 32 Sales of Decongestants by Category: Value 2005-2010
  • Table 33 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 34 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Israel - Category Analysis

HEADLINES

TRENDS

  • On 1 August 2010, the Ministry of Health appointed a new committee to evaluate the current abuse of laxatives within Israel, mainly by young people. It has recently come to the attention of the Ministry of Health that young people are abusing over-the-counter laxatives in order to lose weight. The committee concluded that laxatives containing the active ingredients senna and bisacodyl should be prescription drugs only. This has yet to be made official; however, it is expected to come into force in the short term.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Pharmaceutical Industries Ltd remained the category leader in 2010, with a 27% value share. The company’s leading position within laxatives, where its Laxadin brand accounts for 29% of the category, helped Teva maintain its strong position within digestive remedies. In addition, the launch of Losec within proton pumps inhibitors in 2009 proved successful, with the category growing by 37% in 2010.

PROSPECTS

  • Laxatives are expected to witness slower growth over the forecast period, as the Ministry of Health has put a strong focus on the growing problem of the abuse of such products by young women. Stronger regulations regarding such products are expected, which will make it harder to consume large amounts of laxatives at a time.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 42 Digestive Remedies Company Shares by Value 2006-2010
  • Table 43 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Israel - Category Analysis

HEADLINES

TRENDS

  • During 2010, the main focus within ear care appeared to be ear cleansing, in particular wax softening products. Consumers are becoming more and more aware of their health and appearance, which in 2010 was reflected in increasing awareness of the negative impact of dirty ears and the easy methods available to prevent this problem, which helped sales of ear care.

SWITCHES

COMPETITIVE LANDSCAPE

  • Vitamed is the strongest company in ear care, with a 45% value share in 2010. The company operates one of the strongest brand names in the ear care category: Anaesthetic. Teva Pharmaceutical Industries Ltd was the second strongest player in ear care in 2010 with a value share of 42%. However, it witnessed a decline in value share in that year, of two percentage points. Teva owns the Otidin brand, which is popular amongst parents of young children for treating ear infections.

PROSPECTS

  • Ear care is not a very dynamic environment in terms of innovation and new products, and this is expected to continue to be the case during the forecast period.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2005-2010
  • Table 47 Sales of Ear Care: % Value Growth 2005-2010
  • Table 48 Ear Care Company Shares by Value 2006-2010
  • Table 49 Ear Care Brand Shares by Value 2007-2010
  • Table 50 Forecast Sales of Ear Care: Value 2010-2015
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Israel - Category Analysis

HEADLINES

TRENDS

  • During 2010, concerns were raised regarding the misuse of emergency contraception products by young women. There were fears that such products were being used as a substitute for birth control products such as condoms and standard contraceptive pills.

COMPETITIVE LANDSCAPE

  • Within emergency contraception, only one brand was present in Israel until late 2010: Prostinor. CTS’s Norlevo brand entered the category in December 2010, which meant that Trima Israel Pharmaceutical Products Maabarot Ltd continued to dominate sales in that year, with a 100% value share.

PROSPECTS

  • As the Ministry of Health puts a stronger emphasis on the misuse of emergency contraception products by young women, stricter regulations are expected to be introduced regarding the sale such products, making it harder for emergency contraception to be misused.

CATEGORY DATA

  • Table 52 Sales of Emergency Contraception: Value 2005-2010
  • Table 53 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 54 Emergency Contraception Company Shares by Value 2006-2010
  • Table 55 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 56 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 57 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Israel - Category Analysis

HEADLINES

TRENDS

  • The long 2010 summer in Israel increased demand for eye care products, as the hot humid weather, along with the heavy dust, led to greater use of such products. The main focus in 2010 was on dry eye symptoms, with leading players promoting their products heavily. For example, Teva ran a marketing campaign for its Stilla Singles brand, a pack of disposable transparent eye drops for easier on-the-go use.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Pharmaceutical Industries Ltd was the leading player in eye care in 2010, with a value share of 30%. The company owns the leading brand Stilla, which holds 50% of standard eye care. Pfizer Pharmaceuticals Israel Ltd was the second leading player, with just over 24% of value, with its brand Visine, which leads allergy eye care, with a value share of 62%.

PROSPECTS

  • Leading HMOs are expected to put a stronger emphasis on their private label brands within eye care over the forecast period. This is expected to slow the growth of OTC sales within eye care, as HMOs have a large impact on consumer purchasing habits.

CATEGORY DATA

  • Table 58 Sales of Eye Care by Category: Value 2005-2010
  • Table 59 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 60 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 61 Eye Care Company Shares by Value 2006-2010
  • Table 62 Eye Care Brand Shares by Value 2007-2010
  • Table 63 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 64 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Israel - Category Analysis

HEADLINES

TRENDS

  • Amongst OTC products, herbal/traditional products are less mainstream than standard consumer health products; however, the availability of these products is growing, as consumer awareness of “natural” products increases. The stronger demand for herbal products can be seen within many different markets. Within hot drinks, for example, there has been a rise in consumption of herbal teas, as well new herbal-based fruit juices in soft drinks. Within cosmetics and toiletries, there has been a clear tendency to innovate through focusing on trendy herbal ingredients.

COMPETITIVE LANDSCAPE

  • Chocotrade Ltd continues to lead sales of herbal/traditional products in Israel, with a value share of almost 18% in 2010. The company owns the dominant brand in medicated confectionery, Ricola. Chocotrade witnessed a slight decrease in its share between 2009 and 2010, mainly due to the strong competition from new vitamins and dietary supplements alternatives.

PROSPECTS

  • The health and wellness trend, coupled with the desire for healthier living, is expected to drive growth over the forecast period. Increasing consumer awareness of the vast amount of alternative herbal/traditional remedies in the Israeli market is expected to cause consumers to turn away from conventional OTC products and seek what they regard as more natural alternatives.

CATEGORY DATA

  • Table 65 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 66 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 67 Herbal/Traditional Products Company Shares 2006-2010
  • Table 68 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 69 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 70 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Israel - Category Analysis

HEADLINES

TRENDS

  • Medical devices compete for sales with products in the medicated skin care category, and have tended to gain share at the expense of OTC products in recent years, especially within lice treatments, cold sore treatments and acne treatments. These three treatment areas have seen consistent increases in Israel, as Israeli consumers are constantly affected by these common medical problems. Companies in Israel have realised the strong potential and profit in launching medical devices in medicated skin care products rather than OTC drugs, as the prices of medical devices are not regulated and the profit margins on such products consequently tend to be rather higher than on OTC products. Israeli consumers are often unaware of the difference between medical devices and OTC drugs within these categories, and make their purchasing decisions based mainly according to recommendations and advertising. During 2010, medical device brands increased their presence in lice treatments with two highly successful launches: Resultz and Hedrin.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson Israel Ltd remained the leading company in 2010, with a 17% value share. Its leading brands are Daktarin, which held a 22% value share in topical antifungals, and Nizoral, which held a 45% share in medicated shampoos. Careline (Pharmagis) Ltd was the second strongest player within medicated skin care in 2010, with a value share of 11%. Its leading brand, Agisten, holds 38% of sales of topical antifungals, and continued to be backed heavily by marketing promotions in order to keep awareness high. In 2010, Careline (Pharmagis) Ltd invested US$250,000 in the launch of an internet and in-store promotion marketing campaign under the slogan “Are you itchy? Agisten Aloe Vera and you fungicides will calm down”.

PROSPECTS

  • Medicated skin care is expected to continue to witness fierce competition from non-OTC alternatives, such as medical devices, and other consumer health care products, such as vitamins and dietary supplements, during the forecast period. The competition already being seen in 2010 is expected to intensify.

CATEGORY DATA

  • Table 71 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 72 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 73 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 74 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 75 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 76 Acne Treatments Brand Shares by Value 2007-2010
  • Table 77 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 78 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 79 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Sports Nutrition in Israel - Category Analysis

HEADLINES

TRENDS

  • Value growth of 11% in 2010 was only slightly slower than the review period average. The dynamism of the category has been maintained by the determination of many Israeli consumers to lead healthier lifestyles, including greater participation in sport.

COMPETITIVE LANDSCAPE

  • Teva Sport Castel Ltd continued to be the leading company within sports nutrition in 2010, with a 51% value share. It was followed at some distance by Ambrosia Ltd Solgar, with 8%. Teva Sport Castel Ltd continues to dominate private label sales within sports nutrition, through its TSC brand.

PROSPECTS

  • The forecast period is expected to see particularly strong growth for protein bars, as companies are expected to launch new products and put more emphasis on marketing. The convenience and wide variety of bars are expected to lead to increased sales.

CATEGORY DATA

  • Summary 17 Sports Nutrition: Brand Ranking By Format 2010
  • Table 80 Sales of Sports Nutrition: Value 2005-2010
  • Table 81 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 82 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 83 Sports Nutrition Company Shares 2006-2010
  • Table 84 Sports Nutrition Brand Shares 2007-2010
  • Table 85 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 86 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Israel - Category Analysis

HEADLINES

TRENDS

  • One of the main trends seen within vitamins and dietary supplements in 2010 was stronger segmentation. Nowadays vitamins and dietary supplements can be found targeting a very wide range of medical problems, such as high cholesterol, heart problems and joint problems. Not only are products becoming more medically specific, but they are also becoming more age and gender specific.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Ta’am Teva-Altman General Partnership was the leading player within vitamins and dietary supplements in 2010, with a 28% value share. However, the company saw its share decline by almost three percentage points between 2009 and 2010. This was mainly due to strong competition n from second leading player Ambrosia Ltd Solgar Israel, which increased its share by almost five percentage points, to 26%.

PROSPECTS

  • Over the forecast period, there is expected to a stronger focus on new niche products within dietary supplements, such as sports-specific supplements and weight loss supplements. This type of segmentation will be used by companies as a means to differentiate their products from those of their competitors.

CATEGORY DATA

  • Summary 18 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 87 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 88 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 89 Dietary Supplements by Positioning 2005-2010
  • Table 90 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 91 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 92 Vitamins Brand Shares by Value 2007-2010
  • Table 93 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 94 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Israel - Category Analysis

HEADLINES

TRENDS

  • Obesity and weight gain continues to be a serious problem in Israel amongst both adults and children. Around 600,000 Israelis are obese. The Israel Central Bureau of Statistics (CBS) released data in 2010 suggesting that 58.8% of women in Israel are overweight, while 25.8% are obese. This growing concern has been a major topic in Israel in recent years, as it is now estimated that around 25% of underage children are overweight or obese.

COMPETITIVE LANDSCAPE

  • Super-Pharm (Israel) Ltd overtook market leader Herbalife International of Israel (1990) Ltd in 2010, with a value share of just above 21%, thanks to its holding one of the strongest private label brands within the beauty and personal care market. It is slowly increasing its presence within the wider consumer health environment. Its Life private label is becoming an increasingly well-known household name that consumers tend to trust. Within slimming products, its Diet for Life brand has a strong position in the weight loss supplements niche, where it leads sales.

PROSPECTS

  • Obesity in Israel remains a serious concern for the nation as a whole. This is expected to drive the government to take stronger measures to deal with the problem, which will raise awareness of weight management as a whole.

CATEGORY DATA

  • Table 96 Sales of Weight Management: Value 2005-2010
  • Table 97 Sales of Weight Management: % Value Growth 2005-2010
  • Table 98 Weight Management Company Shares 2006-2010
  • Table 99 Weight Management Brand Shares 2007-2010
  • Table 100 Forecast Sales of Weight Management: Value 2010-2015
  • Table 101 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Israel - Category Analysis

HEADLINES

TRENDS

  • During 2010, the economy in Israel made an almost full recovery, enabling consumers to be a little less concerned about managing their budgets. Within wound care, consumers returned to purchasing well-known brands, such as Band-Aid and Nexcare, while private label brands witnessed a slight decrease in their market share.

COMPETITIVE LANDSCAPE

  • Chemipal Ltd leads wound treatments, with almost 29% of value sales in 2010. Its Nexcare brand has a strong brand presence within all categories, including sticking plasters, with a 20% value share, and gauze, tape and other wound care, with a 36% value share.

PROSPECTS

  • Despite the fact that consumers returned to purchasing well-known brand names in 2010, at the expense of private label brands, private label brands are expected to witness growth over the forecast period. The main reason is the larger shelf space that leading retailers are devoting to their private label brands within wound care, and their lower prices.

CATEGORY DATA

  • Table 102 Sales of Wound Care by Category: Value 2005-2010
  • Table 103 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 104 Wound Care Company Shares by Value 2006-2010
  • Table 105 Wound Care Brand Shares by Value 2007-2010
  • Table 106 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 107 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Black Cohosh
            • Cranberry
            • Isoflavones
            • Mushroom Extract
            • Papaya
            • Pomegranate
            • Saw Palmetto
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Propolis
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report